The Effect of Magnesium Oxide on Plasma Phosphate in Hemodialysis Patients

CompletedOBSERVATIONAL
Enrollment

42

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Hyperphosphatemia
Interventions
DRUG

Mg Oxide

250 mg orally for 4 weeks

Trial Locations (1)

o98-711

Shiraz University Hemodialysis Center, Shiraz

All Listed Sponsors
lead

Shiraz University of Medical Sciences

OTHER

NCT01854437 - The Effect of Magnesium Oxide on Plasma Phosphate in Hemodialysis Patients | Biotech Hunter | Biotech Hunter